Forge Nano, Inc., a leading U.S.-based semiconductor equipment and advanced materials company pioneering Atomic Layer Deposition (“ALD”) technology for artificial intelligence (“AI”)-era chip manufacturing and defense battery applications, which has signed an agreement to merge with Archimedes Tech SPAC Partners II Co. (“Archimedes II”) (NASDAQ: ATII), and Voltaiq, the leading battery intelligence and AI platform, today announced an expansion of their longstanding relationship as Forge Nano moves to rapidly integrate artificial intelligence across its battery operations. As Forge Nano scales from advanced battery development toward high-volume U.S.-based battery manufacturing, the company plans to use AI to accelerate development, improve quality and give its teams faster access to insights from its battery program. Voltaiq will provide the battery-specific data infrastructure and AI-powered analytics platform to support these efforts across R&D, product development, manufacturing and quality.

Nirrin Technologies, a developer of analytical tools designed to transform bioprocessing workflows, will showcase its Tunable Laser Near-Infrared (TL-NIR) platform at the BPI Conference & Exhibition, September 22–25 in Boston, at Booth #831. The TL-NIR platform combines a common hardware foundation with software-enabled analytical workflows, including TALOS™ rapid protein quantitation and ATLAS® multi-analyte quantitation. It is available as an at-line or in-line system, both of which support multiple software workflows. The in-line system can be configured with either a flow cell or in situ probe modality.

Niron Magnetics, the company commercializing the world’s first rare-earth-free Iron Nitride permanent magnets, today announced an investment from Honda Motor Co., Ltd. (“Honda”).

AM Batteries, a leader in dry battery-electrode (DBE) manufacturing technology, announced today its role as a core subrecipient of a $50 million award from the U.S. Department of Energy’s (DOE) Manufacturing Deployment Office (MDO) under the Infrastructure Investment and Jobs Act.

Valgotech LLC, a U.S. developer of advanced battery systems for defense and commercial applications, announced a new hybrid battery pack architecture designed to optimize the high energy-density advantages of lithium-metal and lithium-ion battery technologies.

NTx Bio, a leader in next-generation biomanufacturing technologies, announced that its NTxscribe® CORE platform is being used by researchers at Baylor College of Medicine to manufacture mRNA for a personalized dendritic cell vaccine (DCV) now in clinical use in an industry-sponsored Phase 1 trial for refractory melanoma, marking one of the first publicly disclosed clinical translations of NTx’s continuous-flow manufacturing platform.